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1078–5884/00The Influence of Cryopreservation on Changes
in Diameter and Compliance of Allografts in an
Animal Experimental Model
M. Gabriel,1* K. Wachal,1 L. Dzieciuchowicz,1 K. Pawlaczyk,2
Z. Krasin´ski1 and G. Oszkinis1Departments of 1Vascular Surgery, and 2Hypertension and Vascular and Internal Diseases, University of
Medical Sciences, Poznan, PolandObjective. The purpose of this study was to analyze the influence of cryopreservation on changes in diameter and
compliance of allografts.
Methods. Sixty aortic allografts implanted in situ in rats were analyzed. The animals were divided into four groups that
received fresh or cryopreserved isogenic (Lewis to Lewis) grafts, or fresh or cryopreserved allogenic (Lewis to DA) grafts,
respectively. The diameter and compliance of the grafts were then visually evaluated with the digital video camera recorder
after 15, 30, 60, 90 and 120 days.
Results. Gradual increase in diameter and decrease in compliance in case of all allogenic and cryopreserved isogenic grafts
were observed. The observed changes in cryopreserved grafts were smaller when compared with fresh grafts, however, the
differences did not reach statistical significance.
Conclusion. Cryo preservation does not protect allografts from stiffening and dilatation.Keywords: Arterial allograft; Cryopreservation; Compliance; Animal model.Introduction
Implantation of vascular allografts is one of the
principal methods of vascular reconstruction
following removal of infected grafts.1,2 Unfortu-
nately, although early results are very satisfying,
there is a substantial number of long-term compli-
cations. The most important complications are
segmental stenosis or dilatation, thrombosis, crack-
ing of the wall or disruption of the anastomosis
leading to development of pseudoaneurysms.3,4 It
can be assumed that development of these long-
term complications results from remodeling of
histological structure of blood vessels and changes
in mechanical properties of the grafts. Both these
phenomena are associated with chronic rejection
reaction.5,6 Taking into the account limited possibi-
lities of antigen matching between recipient and
donor of allograft, physical methods of preservation
were proposed to decrease unfavorableing author. Marcin Gabriel, MD, PhD, Department of
ery, University of Medical Science, ul. Dluga 1-2, 61-
oland.
: mgabriel@pro.onet.pl
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these methods is cryopreservation. The studies on
the influence of cryopreservation on the mechanical
properties of grafts have shown inconsistent results.
There have been reports of beneficial influence of
cryopreservation on the maintenance of cell func-
tion and mechanical properties.8,9 On the other
hand, the harmful effect of freezing on different cell
populations, contractile function of the vessel wall
and possibility of cracking of the vessels have been
reported.10,11 The purpose of this study was to
analyze the influence of cryopreservation on
changes in physical properties of allografts in an
animal experimental model.Material and MethodsDonors
Sixty male Lewis rats were used as donors of the
abdominal aorta.Eur J Vasc Endovasc Surg 32, 169–175 (2006)
doi:10.1016/j.ejvs.2006.01.025, available online at http://www.sciencedirect.com onved.
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Thirty male DA and 30 Lewis (Lew) rats were used.
The recipients were divided into four groups of 15 rats
each:
1. Group I—received fresh isogenic grafts (Lew to
Lew)
2. Group II—received cryopreserved isogenic grafts
(Lew to Lew)
3. Group III—received fresh allogenic grafts (Lew to
DA)
4. Group IV—received cryopreserved allogenic grafts
(Lew to DA)
All animals came from the Center of Experimental
and Clinical Medicine of the State Academy of
Science in Warsaw. The rats were housed and
operated on in the animal laboratory of the Chair
of Toxicology, University of Medical Sciences in
Poznan´. The animals were 14–16 weeks old and
weighed from 250 to 350 g.Anesthesia and operative technique
The rats were anesthetized with subcutaneous
administration of ketamine (70 mg/kg of body
weight) and xilazine (6 mg/kg of body weight).
The peritoneal cavity was entered through a midline
incision. The infrarenal abdominal aorta was
exposed by blunt dissection. The lateral aortic
branches were ligated with a monofilament suture
10/0 and a 20 mm segment of aorta was harvested
from the donors. Directly before harvesting the
external diameter (d0) and the compliance (C0) of
the donor aorta were measured using the technique
described below. In recipients, a 10 mm segment of
the infrarenal aorta was excised and the harvested
segment of aorta was implanted in situ. The
anastomosis was performed in an end-to-end fashion
with a continuous, nonabsorbable monofilament
suture 9/0 (Ethilon, Ethicon). After completion of
the anastomosis the aorta was declamped and
quality of the anastomosis was assessed. Then the
external diameter (d1) and compliance (C1) of
the implanted segment of the aorta were measured.
The peritoneal cavity was rinsed with a solution of
povidone iodine and the abdomen was closed in a
bilayered fashion with an absorbable suture 4/0
(Dexon). Immediately after the surgery all animals
were given 10 ml of physiologic saline subcu-
taneously and placed in single cages.Eur J Vasc Endovasc Surg Vol 32, August 2006Allografts preservation
The fresh allografts were harvested directly before
implantation. After harvesting they were kept in a
physiologic saline solution at a temperature of 4 8C for
20–30 min. The cryopreserved grafts were frozen in
RPMI 1640 solution enriched with 10% DMSO, 10%
FCS, 2 mmol/l glutamine and Na-pyruvate. The
specimens were frozen at a constant, controlled rate
of K1.1 8C/min using computerized freezer ‘IceCube
1610’, according to the experimentally determined
gradient. When the temperature reached K80 8C, the
frozen grafts were transferred to liquid nitrogen where
they were kept for 10 days. Directly prior to
implantation, they were thawed in a water bath at a
temperature of 37 8C. The medium was gradually
diluted with physiologic saline. The grafts were rinsed
three times in physiologic saline and implanted as
described above.Measurement of the diameter and compliance of the grafts
After 15, 30, 60, 90 and 120 days three rats from every
group were anesthetized. Two hundred units of
unfractioned heparin were given subcutaneously and
the graft was exposed with blunt dissection. To
achieve better visualization of the graft, a piece of
plastic was put posteriorly to the graft. After
hemostasis was accomplished, the peritoneal cavity
was filled with physiologic saline to prevent tissue
desiccation. The external diameter and cyclic changes
in the diameter of the grafts were recorded with a
digital video camera recorder DCR-PC100E, 1 mega-
pixel (Sony). The images were then transferred to a
computer and processed with Pinnacle Studio 7.13
software. To avoid changes in hemodynamic par-
ameters recording time did not exceed 10 s. The
maximal diameter of graft corresponding to systolic
peak and minimal diameter of the graft corresponding
to an end diastole were measured through the slow
motion option. The measurement of external diameter
of the graft had the accuracy of 0.05 mm. Both absolute
[dxKd0] and relative [(dxKd0)/d0] changes in the
external diameter of the grafts were calculated. The
arterial blood pressure was invasively measured with
the catheter introduced through the iliac artery. The
compliance was calculated according to the following
formula:
CZDd=Dpðmm2=mmHgÞ
where C, compliance; Dd, systolic–diastolic difference
in graft diameter; Dp, difference between systolic and
diastolic blood pressure.
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Segments of rat aorta obtained directly after harvest-
ing and after thawing as well as specimens of arterial
iso- and allografts obtained 15, 30, 60, 90 and 120 days
after implantation underwent histology and immu-
noenzymatic examination. Paraffin sections 5 mm thick
stained with hematoxilin and eosin and Mason-
trichrome were prepared for examination. Five
micrometer thick sections were staining with anti-
bodies against Actin (Immunotech), Vimentin (Immu-
notech), B and T lymphocytes (MRC OX3, Serotec, Ki-
T1R), endothelial cells (OX43, Sera-Lab), macrophages
(Ki-M2R) and proliferating cells (Ki-S3R). All anti-
bodies of Ki-.R series came from Institute of
Immunology of CAU-Kiel.12
The study was approved by the Ethics Commitee at
the Karol Marcinkowski University of Medical
Sciences in Poznan.
The data were analysed using the Statistica software
package (StatSoft). The nonparametric Wilcoxon test
was used to compare changes within the groups and
nonparametric Mann–Whitney test was used to
compare the differences between the groups. Differ-
ences were considered significant with p!0.05.ResultsFig. 1. The relative changes in the external diameter of aortic
grafts within 120 days following implantation. Group I—
fresh isogenic grafts, group II—cryopreserved isogenic
grafts, group III—fresh allogenic grafts, group IV—cryopre-
served allogenic grafts.External diameter of the graft
The mean diameter of the infrarenal aorta in donor
Lewis rats was 1.56 mm (G0.2). The preservation of
fresh grafts in physiologic saline at 4 8C for 20–30 min
did not influence the diameter of the graft. After the
first 15 days there were no changes in the diameter of
the grafts in animals from group I. Starting from the
30th day gradual dilatation of the grafts was observed.
A mean increase of 10.7% in the diameter of the grafts
from the day of implantation to 120th day was noted
(pZ0.013). For cryopreserved isogenic grafts a 15.3%
increase in the diameter of the grafts was observed
directly after implantation (pZ0.042). In further
measurements a gradual increase in diameter of the
grafts was observed. At the 120th day 37.2% dilatation
was noted. In animals from group III slight but
statistically insignificant decrease in diameter of the
grafts directly after implantation was noted. Then the
diameter of the grafts increased gradually, with
the fastest growth between 30th and 60th day. The
overall increase in diameter in group III was 62%. In
group IV, a mean 22.1% dilatation of the grafts directly
after implantation was observed (pZ0.006).Subsequent measurements showed further dilatation
of the grafts with the fastest growth between the 60th
and 90th day. The overall increase in diameter in group
IV was 54.8% (p!0.001). Taking into the account the
dilatation related to cryopreservation, the relative
increase in diameter in group IV was 26.8% (pZ
0.002). Both absolute and relative increases in diameter
of the grafts were significantly higher in groups III and
IV when compared to group I (p!0.002). There were
no statistically significant differences between changes
in groups II, III and IV (pZ0.93) (Fig. 1).Compliance
Compliance of the abdominal aorta in donor rats prior
to harvesting was 12.3G1.2 mm2/mmHg. In the
beginning there was a decrease in compliance of
the grafts in animals from group I. From the 60th day
the compliance increased to reach 103.9% of the initial
value on the 120th day (pZ0.004). The compliance of
cryopreserved isogenic grafts measured directly after
implantation was increased by 5.1%. Starting from the
15th day the compliance in this group decreased to
reach 92.3% of the initial value on the 120th day (pZ
0.056). In animals from group III the short-lasting
increase observed on the 15th day (pZ0.038) was
followed by gradual decrease in the compliance. At
the final measurement the compliance was decreased
by 15.02% comparing to the initial value (p!0.001). In
animals from group IV significant increase of com-
pliance directly after implantation was observed
(6.7%, p!0.001). This increase in compliance in this
period was significantly higher when compared to
other groups (p!0.039). Starting from the 30th day
gradual reduction of compliance was noted. At the
final measurement the compliance was decreased by
7.72% compared to the initial value (p!0.001) (Fig. 2).Eur J Vasc Endovasc Surg Vol 32, August 2006
Fig. 2. The relative changes in the compliance of aortic grafts
within 120 days following implantation. Group I—fresh
isogenic grafts, group II—cryopreserved isogenic grafts,
group III—fresh allogenic grafts, group IV—cryopreserved
allogenic grafts.
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strated a relative increase of compliance at the end of
the observation period. In the remaining three groups
the compliance decreased. There were significant
differences in the relative changes of compliance
between group I and groups III and IV (pZ0.002).
The differences between groups II, III and IV were not
statistically significant (pZ0.21).Histology and immunoenzymatic analysisAnalysis of cryopreserved grafts after thawing
In all cryopreserved vessels total loss of the endo-
thelium was observed. The spatial structure of the
media was generally intact when compared with fresh
specimens. There were small foci of unstained cells
between layers of myocytes. A concentric arrangement
of elastic fibers was maintained in all layers without
any signs of fragmentation. Regardless of antigen
matching of the specimens and method of preser-
vation the defects in the intimal lining were filled with
endothelium between 15th and 30th days of obser-
vation (Fig. 3).Fig. 3. Change in number of cell nuclei of all three layers of
the vascular graft implanted in animal model in relation to
duration of functioning. [a] intima; [b] media; [c] adventitia.
The yellow area marks a normal range.Analysis of fresh isogenic grafts (group I)
No smooth muscle or inflammatory cells were demon-
strated within the intima in any of the study periods.
There were no significant changes in the structure of
media and adventitia. The greatest intensity of T
lymphocytes andmacrophages infiltrates were present
on the 30th day of the observation. These gradually
resolved during the rest of the study period. Starting
from the 15th day, proliferation of fibroblasts in the
adventitia was noted. Later in the observation period
adventitial fibrosis was demonstrated.Analysis of frozen isogenic grafts (group II)
Early in the observation period intimal infiltrates of T
lymphocyte and macrophages were noted. TheseEur J Vasc Endovasc Surg Vol 32, August 2006resolved completely after 60 days. Beginning from
30th day a few cells with positive reaction to Ki-S3R
and MRC OX3 antibodies and to monoclonal antibody
against actin and vimentin started to appear.
Starting from the 7th day significant decrease in
number cell nuclei was observed in the media. Starting
from the 15th day scarce infiltrates of T lymphocytes
and macrophages occurred and from 30th day the
proliferation of fibroblasts was increased.
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phages between 7th and 90th day and significant
increase in amount of fibroblasts beginning from the
30th day were observed in contrast to group I.C4. Fresh and cryopreserved allografts (groups III and IV)
The nature and dynamics of the changes occurring
in structure of both fresh and cryopreserved
allografts were comparable. In the intima, starting
from the 15th day infiltrates of T and B lymphocytes
and macrophages and were demonstrated in the
subendothelial layer. Beginning from the 30th day
cells with positive staining with Ki-S3R and, MRC
OX3 antibodies and antibodies against actin and
vimentin emerged. Progressive proliferation of
smooth muscle cells and fibroblasts was
accompanied by constant increase of thickness of
intima. In the last study period cell density was
significantly greater than seen initially (p!0.002).
While there were no statistically significant differ-
ences in the changes of cell density between group
III and IV (pZ0.554), the changes in groups III and
IV was significantly greater when compared to
group I and II (p!0.006).
Within the media, from the 7th day the number of
cell nuclei decreased. In the case of frozen grafts the
initial number was 30% smaller than in fresh grafts
and a similar difference was maintained throughout
entire observation period. The number of cells reached
the lowest level between 30th and 60th day of the
study. In this period, only isolated muscle cells
surrounded by inflammatory cells were seen. At the
same time cells with a positive reaction to vimentin
gradually increased. The broken integrity of elastic
fibers, that was observed in six specimens, was the
entry point for migration of cells from the media and
adventitia to the intima.
Within the adventitia, rapid increase of cell
number was secondary to an influx of T lympho-
cytes and macrophages. The intensity of infiltration
reached its peak on the 60th day of the observation.
On the 90th and 120th days of the study single
mononuclear cells mainly macrophages and B
lymphocytes were present. Between the 15th and
90th days the changing number of proliferating cells
(positive reaction for Ki-S3R and mAb against
vimentin) were observed. The changes in number
of cells between extreme measurements was insig-
nificantly greater in group IV (pZ0.554). The
changes in number of cells in both allogenic groups
differed significantly from the range of changes in
group I (pZ0.017).Discussion
The relation between long-term complications and
remodeling of vascular grafts has been previously
demonstrated. Both the intensity and duration of
chronic rejection reaction are related to antigenicity
of the transplanted material.5,6 Cryopreservation is
one of the methods to reduce the antigen load of
the donor graft.13 According to Giglia8 and Petersen14
the process of controlled freezing is supposed to limit the
chronic rejection reaction and decrease ‘immunologic’
dilatation of allografts. They found that cryopreserva-
tion eliminates aneurysmal dilatation in an animal
model. These results have not been confirmed in our
study. Indeed we found that cryopreservation limited
dilatation and compliance reduction, but the extent of
these changes was nonetheless significantly bigger
than in fresh isogenic grafts. Moreover, cryopreserva-
tion in the isogenic model increased diameter and
decreased compliance when compared to fresh
isogenic grafts. The differences between the results of
Giglia and Petersen and ours could be due to
difference in observation periods. Their study lasted
only 8 weeks while ours was 10 weeks longer. We
observed the acceleration of dilatation and changes in
compliance 8 weeks after implantation, thus shorter
observation periods would not be enough to detect
these changes. The failure of cryopreservation to
significantly limit inflammatory reaction and extent
of histological remodeling following implantation of
allografts has been reported by other authors.15,16
A Standardized process of cryopreservation enables
the maintenance of intact spatial structure of collagen
and elastin fibers.17,18 However, cryopreservation and
storage of the grafts are associated with significant loss
of smooth muscle cells and changes in their function.19
This results in dilatation of thawed grafts and transient
growth of their compliance.20
Changes of elastic properties of vascular grafts are
accompanied by remodeling of the vessel wall
expressed by its thickening and domination of intimal
hyperplasia.20 These processes are stimulated by the
inflammatory reaction within the graft wall induced
by necrotic lesions occurring during the preservation
process.15
Although normal morphology is apparently main-
tained, function of cryopreserved endothelial cells is
modified. Isolated and cultured cell maintain their
fibrinolytic properties and ability to excrete prostacy-
clins, however, this function is attenuated with long-
lasting preservation.21 The endothelium-dependent
contractility of smooth muscle cells mediated by
thrombin and acetylcholine is similarly impaired.22Eur J Vasc Endovasc Surg Vol 32, August 2006
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reversed even during long-term in vitro culture.
The loss of ability to withstand high pressure by
endothelial cells seems extremely important,21 and
may be responsible for the total loss of endothelial
cells by blood flow in the 1st day following
implantation.23 Thickening of the intima is the next
critical finding. The first signs of this process can be
observed in small arteries as soon as 7 days after
transplantation and these initial changes are caused
by infiltrations of inflammatory cells.24 Starting from
the 14th day gradual migration of smooth muscle
cells from media to the intima was observed.25 The
process of cell migration is enhanced by increased
activity of metalloproteinases, mainly 1, 3 and 9,
which are responsible for degradation collagen and
elastin elements.14,26 Smooth muscle cells migrating
to the intima undergo proliferation. Some authors
report coexisting phenotype transformation of pro-
liferating myocytes.25,27 This transformation involves
gradual loss of ability to contract and to produce
a-actin, typical functions of mature cells, and
replacement with a mechanism of synthesis and
excretion of b-actin, which typical for fetal myo-
cytes.27 This type of transformation can be respon-
sible for changes in the structure of matrix.28,29
Campbell suspects, that phenotype transformation
results from abolition of endothelial control after the
endothelium is exfoliated. In cultures of myocytes
the process of phenotype transformation is inhibited
in the presence of endothelial cells but not
fibroblasts.27
Gradually decreasing number of myocytes is the
main change in media. Cryopreservation alone is
responsible for death of half of the cells. Such a crucial
difference in comparison with percentage of living
endothelial cells is most frequently explained by the
limited possibility of cryoprotectant penetration to
deeper layers of the arterial wall.13,21 Further destruc-
tion is done by inflammatory cells, which are mainly
present in the external part of the intima. The severity
of this process is related to the degree of antigen
mismatch.24 The third mechanism responsible for
decreasing number of smooth muscle cells in the
media of the allografts, namely apoptosis, is more and
more oftenmentioned. Hirsch and Bergese believe that
this process is responsible for the death of approxi-
mately 10% of myocytes and involves mainly areas of
the vessel wall free of inflammatory infiltrate.11
Although apoptosis could be generally observed
within 2 weeks following implantation, the timing of
the peak intensity of this process depends on the
degree of antigen matching between a donor and a
recipient. In the case of lack of compatibility the peakEur J Vasc Endovasc Surg Vol 32, August 2006intensity occurs between the second and 14th day
while in case of good matching between the 8th and
20th day.11
Both cryopreservation and inflammatory reaction
accompanying graft implantation augment natural
degradation of elastin and collagen fibers.30 Bujan and
Bellon showed that increased activity of metallopro-
teinases (MMP) 1, 2 and 9 can be observed in thawed
and kept alive cryopreserved arterial allografts.15,26
The activity of MMP-1, responsible for degradation of
collagen, increases directly after thawing.15 However,
MMP-9, which is not present in fresh and cryopre-
served vessels, is supposed to play a crucial role in
tissue remodeling following transplantation.26
Since, the smooth muscle cells lose their ability to
produce elastin the lost elastin fibers cannot be
replaced.31 Later on collagen, mainly type I and III, is
synthesized by the myocytes and fibroblasts.30 The
synthesis of collagen is stimulated by the co-existing
inflammatory process, that leads to increased amount
offibroblasts and increased expression of procollagen I
and III genes.32 Both donor fibroblasts, the ones that
survived cryopreservation, and recipient fibroblasts
migrating to the graft may be involved in that process.
Analysis of histology specimens in rats showed that in
the majority of cases remodeling slows gradually after
approximately 90 days which correlates with the
changes in compliance of the grafts.
In our in vivo study, a decrease in diameter of
transplanted aortas from Lew recipients to DA donors
was observed. The difference in arterial blood pressure
between Lew and DA rats may be responsible for this
fact. The lower blood pressure in DA rats causing
lower stretching forces could result in both decrease of
diameter and transient growth of compliance in group
III.
Although the process of gradual dilatation of
allografts may lead to development of late clinical
complications, it may also be beneficial to some extent.
It maintains internal diameter of the graft in the
presence of intimal thickening that occurs in
implanted vessels irrespectively of the degree of
antigen matching and the method of preservation. It
also enables stabilization of wall tension in the
presence of its growing stiffness, which reduces the
differences in mechanical properties between contig-
uous segments of the vessels.33
In conclusion, the implantation of cryopreserved
isogenic and fresh and cryopreserved allogenic grafts
is associated with their subsequent dilatation and
decrease of their compliance. The cryopreservation
does not significantly protect allografts from dilatation
and decrease of compliance.
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